Test Price
7,600 AED✅ Home Collection Available
Oncomine™ Comprehensive Assay in UAE | AED 7600 | Genomic Tumor Profiling
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity through ISO 9001:2015‑certified NGS workflow. Secure medical courier solid tissue specimen retrieval from accredited hospitals. Telephonic post‑test clinical guidance included. Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Oncomine Comprehensive Assay is a cutting‑edge Next‑Generation Sequencing (NGS) panel that analyses 143 cancer‑associated genes from tumour tissue, delivering actionable genomic insights for personalised oncology. In the UAE, this assay is performed under strict DHA mandate and full compliance with UAE PDPL data privacy standards.
| Feature | Oncomine Comprehensive Assay (Our Test) | Standard Single‑Gene / Limited Panel |
|---|---|---|
| Genomic Coverage | 143 genes (SNVs, CNVs, fusions) | 1–50 genes |
| Methodology | NGS with ISO 9001:2015‑validated bioinformatics | Sanger sequencing or basic NGS |
| Turnaround Time | 2‑3 weeks | 2‑4+ weeks |
| UAE DHA Accreditation | Yes (Facility License: 1143) | Variable |
| Sample Requirement | Tumour tissue (FFPE/fresh) – Secure medical courier retrieval | Often requires larger tissue or multiple draws |
| Cost | AED 7,600 | AED 3,000 – 10,000 |
Physician Insight & Safety Protocols
"Every patient’s journey with cancer is deeply personal; our genomic analysis is designed to empower your oncologist with precise molecular information, not replace clinical judgement. I urge you to correlate all findings with your full clinical picture, imaging, and pathology. Trust that you are not alone – our post‑test guidance bridges the gap between complex data and compassionate care."
— Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011
Advisory – Medication Continuity
Do not discontinue any prescribed medication without prior consultation with your treating physician. The genomic report is a supplementary tool and does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Emergency Red Flags
- Unsuitable tumour sample: necrotic tissue, less than 20% tumour cellularity, or decalcified bone.
- Active bleeding disorders or recent biopsy complications – seek urgent medical care.
- If you experience rapid symptom progression, severe pain, or shortness of breath, call emergency (998) or proceed to the nearest ER.
Patient FAQ & Clinical Guidance
1. What is the Oncomine Comprehensive Assay used for in clinical practice?
The Oncomine Comprehensive Assay identifies targetable mutations in 143 cancer genes to guide personalized oncologic therapy. It is primarily used to detect single nucleotide variants, copy number alterations, and gene fusions from solid tumour tissue, enabling oncologists to match patients with approved targeted therapies or clinical trials. The test is ordered by general physicians, insurance medical examiners, or proactive individuals who wish to understand genetic drivers of malignancy.
2. Do I need a doctor’s prescription for this test in the UAE?
A valid DHA‑registered physician’s prescription is mandatory for all patients except those undergoing elective surgery, pregnant women with suspected hereditary risks, and individuals requiring documentation for international travel. In those exempt cases, a pre‑genetic counselling session is provided to ensure informed consent, in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
3. How long does it take to receive results, and how are they delivered?
Results are delivered within 2‑3 weeks via a secure portal, with included telephonic clinical guidance. Once sequencing and bioinformatic analysis are complete, a comprehensive report is uploaded to our encrypted patient portal. A dedicated clinical counsellor then calls you to explain the findings, discuss actionable mutations, and coordinate with your treating physician. The report highlights FDA‑approved therapies and clinical trial options aligned with UAE healthcare standards.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All genomic data processing and storage strictly adhere to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent for specimen collection and genetic analysis is obtained under Federal Decree‑Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License No. 1143 and follows ISO 9001:2015 standards for quality management.
Your genomic information is encrypted, access‑controlled, and never shared without explicit consent. For any privacy‑related queries, contact our Data Protection Officer at dpo@dnalabsuae.com.
Clinical & Logistical Metadata
| Test Name | Oncomine™ Comprehensive Assay (NGS Solid Tumor Panel) |
| Price (AED) | 7,600 |
| Turnaround Time | 2–3 weeks |
| Sample Type / Matrix | Tumor tissue (FFPE blocks or fresh biopsy) – Secure Medical Courier Solid Tissue Specimen Retrieval. Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Next‑Generation Sequencing (NGS) with ISO 9001:2015‑validated bioinformatics pipeline |
| ICD‑10‑CM Code | C80.1 (Malignant neoplasm, unspecified), Z15.01 (Breast cancer susceptibility), Z15.09 (Other malignant neoplasm susceptibility) |
| LOINC Code | 85252‑0 (Solid tumor panel by NGS) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians